Food and Drug Administration "Zyprexa-statistical review and evaluation" 16 April 2001: 28 pages.
(2001), pp. 28
5
0036244492
"A double-blind, placebo-controlled dose response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia"
Breier A et al. "A double-blind, placebo-controlled dose response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia" Arch Gen Psychiatry 2002; 59 (5): 441-448.
"Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia"
Wright P et al. "Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia" Am J Psychiatry 2001; 158: 1149-1151.
Food and Drug Administration "Review and evaluation of clinical data" 15 April 2001: 115 pages.
(2001), pp. 115
8
84856542980
"European Public Assessment Report" - Olanzapine Scientific Discussion"
The European Agency for the Evaluation of Medicinal Products Committee for Proprietary Medicinal Products London 26 February
The European Agency for the Evaluation of Medicinal Products Committee for Proprietary Medicinal Products "European Public Assessment Report" - olanzapine Scientific Discussion" Rev. 18; London 26 February 2003: 25 pages.
"A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, on placebo in treating acutely agitated patients diagnosed with bipolar mania"
Meehan K et al. "A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, on placebo in treating acutely agitated patients diagnosed with bipolar mania" J Clin Psychopharmacol 2001; 21 (4): 389-397.
"Addendum briefing document for Zyprexa intramuscular (olanzapine for injection)"
Eli Lilly and Company 19 January
Eli Lilly and Company "Addendum briefing document for Zyprexa intramuscular (olanzapine for injection)" 19 January 2001; 49 pages.
(2001), pp. 49
11
0037628108
"Effects of intramuscular olanzapine vs haloperidol and placebo on QTc intervals in acutely agitated patients"
Lindborg SR et al. "Effects of intramuscular olanzapine vs haloperidol and placebo on QTc intervals in acutely agitated patients" Psychiatry Res 2003; 119: 113-123.
